1 |
Aoyagi, T., Wada, T., Nagai, M., Kojima, F., Harada, S., Takeuchi, T., Takahashi, H., Hirokawa, K. and Tsumita, T. (1990) Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease. Experientia 46, 94-97
DOI
|
2 |
Park, Y.-S., Jang, H.-J., Lee, K.-H., Hahn, T.-R. and Paik, Y.-S. (2006) Prolyl endopeptidase inhibitory activity of unsaturated fatty acids. J. Agric. Food Chem. 54, 1238- 1242
DOI
ScienceOn
|
3 |
Lee, J.-H., Lee, S.-Y., Lee, K.-S., Jang, H.-J., Lee, K.-H., Hahn, T.-R. and Paik, Y.-S. (2004) Prolyl endopeptidase inhibitors from the leaves of Ginkgo biloba. Planta Med. 70, 1228-1230
DOI
ScienceOn
|
4 |
Parle, M. and Dhingra, D. (2003) Ascorbic acid: a promising memory-enhancer in mice. J. Pharmacol. 93, 129-135
DOI
|
5 |
Kimura, K., Kawaguchi, N., Yoshihama, M. and Kawanishi, G.. (1990) Staurosporine, a prolyl endopeptidse inhibitor. Agric. Biol. Chem. 54, 3021-3022
DOI
ScienceOn
|
6 |
Odaka, C., Mizuochi, T., Shirasawa, T., Morain, P. and Checler, F. (2002) Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death. FEBS Lett. 512, 163-167
DOI
ScienceOn
|
7 |
Kalwant, S. and Porter, A. G.. (1991) Purification and characterization of human brain prolyl endopeptidase. Biochem. J. 276, 237-244
DOI
|
8 |
Morris, M. C., Beckett, L. A. and Scherr, P. A. (1998) Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alz. Dis. Assoc. Disord. 12, 121-126
DOI
ScienceOn
|
9 |
Duffy, S. J., Gokce, N., Holbrook, M., Huang, A., Frei, B., Keaney Jr, J. F. and Vita, J. A. (1999) Treatment of hypertension with ascorbic acid. The Lancet 354, 2048-2049
DOI
ScienceOn
|
10 |
Solfrizzi, V., Panza, F., Torres, F., Mastroianni, F., Del Parigi, A., Venezia, A. and Capurso, A. (1999) High monounsaturated fatty acids intake protects against agerelated cognitive decline. Neurology 52, 1563-1569
DOI
ScienceOn
|
11 |
Haag, M. (2003) Essential fatty acids and the brain. Can. J. Psychiatr. 48, 195-203
DOI
|
12 |
Padayatty, S. J. and Levine, M. (2000) Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity. J. Am. Coll. Nutr. 19, 423-425
DOI
|
13 |
Markesbery, W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radical Bio. Med. 23, 134-147
DOI
ScienceOn
|
14 |
Walter, R., Shlank, H., Glass, J. D., Schwartz, I. L. and Kerenyi, T. D. (1971), Leucylglycinamide released from oxytocin by human uterine enzyme. Science 173, 827-829
DOI
ScienceOn
|
15 |
Song, K.-S. and Raskin, I. (2002) A prolyl endopeptidaseinhibiting benzofuran dimer from Polyozellus multiflex. J. Nat. Prod. 65, 76-78
DOI
ScienceOn
|
16 |
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten J. C., Hofman, A., Witteman, J. C. and Breteler, M. M. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J. Amer. Med. Assoc. 287, 3223-3229
DOI
ScienceOn
|
17 |
Frank, B. and Gupta, S. (2005) A review of antioxidants and Alzheimer's disease. Ann Clin. Psychiatr.17, 269-286
DOI
ScienceOn
|
18 |
Masaki, K. H., Losonczy, K. G., Izmirlian, G., Foley, D. J., Ross, G. W., Petrovitch, H., Havlik, R. and White, L. R. (2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54, 1265-1272
DOI
ScienceOn
|
19 |
Yoshimoto, T., Walter, R. and Tsuru, D. (1980) Proline-specific endopeptidase from Flavobacterium. Purification and properties. J. Biol. Chem. 255, 4786-4792
|
20 |
Park, Y.-S., Jang, H.-J. and Paik, Y.-S. (2005) Prolyl endopeptidase inhibitory activity of ursolic and oleanolic acids from corni fructus. Agric. Chem. Biotechnol. 48, 207- 212
|
21 |
Cunningham, D. F. and O'Connor, B. (1997) Proline specific peptidase. Biochem. Biophys. Acta 1343, 160-186
DOI
ScienceOn
|